Clinical Trial

Modified Conditioning Regimen for CML-BP

Name: Modified Conditioning Regimen for CML-BP — clinical trial record (NCT07259161)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Study on the Efficacy and Safety of a Reduced-Toxicity Conditioning Regimen Containing Thiotepa and Melphalan in Patients with Blast Phase Chronic Myeloid Leukemia

Trial Details

NCT Number	NCT07259161
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	CML,Blast Phase, HSCT
Enrollment	40 participants
Start Date	2025-12-15
Primary Completion	2029-09-14 (estimated)
Study Completion	2029-09-14 (estimated)
Updated on ClinicalTrials.gov	2025-12-02